{"denoms":[{"counts":[{"groupId":"BG000","value":"287"}],"units":"Participants"}],"groups":[{"description":"Treatment consists of 3 cycles of Doxorubicin hydrochloride IV (25 mg/m2) days 1 \\& 2, Vincristine sulfate IV (1.4 mg/m2 \\[max 2.8 mg\\]) Days 1 \\& 8, Prednisone orally (40 mg/m2) Days 1-7, Cyclophosphamide IV (600 mg/m2) Days 1 \\& 2, Filgrastim by mouth or IV (5 micrograms/kg/dose) 24 hours after Cyclophosphamide complete. See detailed description for remainder of therapy.\n\nradiation therapy: Undergo radiation therapy\n\ndoxorubicin hydrochloride: Given IV\n\nvincristine sulfate: Given IV\n\nprednisone: Given orally\n\ncyclophosphamide: Given IV\n\nifosfamide: Given IV\n\nvinorelbine tartrate: Given IV\n\ndexamethasone: Given IV\n\netoposide phosphate: Given IV\n\ncisplatin: Given IV\n\ncytarabine: Given IV\n\nfilgrastim: Given IV or subcutaneously","id":"BG000","title":"Doxorubicin, Vincristine, Cyclophosphamide and Filgrastim"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"272"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"15"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"3","upperLimit":"21","value":"15"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"160"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"127"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"227"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"17"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"8"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"29"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"220"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"27"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"250"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Australia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Israel"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Mexico"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"New Zealand"},{"categories":[{"measurements":[{"groupId":"BG000","value":"4"}]}],"title":"Puerto Rico"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Switzerland"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}]}